Indiana Daily Student

U.S. Food and Drug Administration grants Pfizer-BioNTech vaccine full approval Monday

<p></p>

The U.S. Food and Drug Administration granted the Pfizer-BioNTech coronavirus vaccine full approval for individuals age 16 and older Monday, according to the FDA website

The vaccine, now known as Comirnaty, is also available under emergency use authorization for those ages 12 to 15, and a third dose is available for certain immunocompromised individuals.

Fully vaccinated adults should prepare to get a third booster shot of the COVID-19 vaccine eight months following their second dose, the Biden Administration announced Aug. 18.

The approval of the Pfizer vaccine is expected to expand mandates for the COVID-19 vaccine, according to the New York Times. Some private and public organizations were awaiting final approval before requiring the vaccine.

All Indiana University campuses required students, faculty and staff to receive the COVID-19 vaccine before returning to campus for the fall 2021 semester. The Supreme Court rejected a lawsuit to overturn IU’s requirement Aug. 12.

Like what you're reading?

Stay on top of the COVID-19 and vaccination news. This weekly newsletter will package our coverage of cornavirus news, updates and the critical information you need to know.

Signup today!
Like what you're reading? Support independent, award-winning college journalism on this site. Donate here.

Powered by Solutions by The State News
All Content © 2022 Indiana Daily Student